Step by Step

INTRODUCTION

3-28-2023 - Medical Grand Rounds: Bench to Bedside -Innovations in Improving Care for Patients with Chronic Kidney Disease

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Recognize the challenges in CKD management 
  • Describe newer models of CKD care delivery 
  • Examine Multi-disciplinary Team approach for CKD
  • Explain how renal denervation is a novel treatment for both HTN and CKD
  • Evaluate how inflammation (or other factors) increase sensory nerve activity in kidney injury
  • Describe sensory nerve ablation reduces BP and increases GFR

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

Suggested additional reading:

  1. Chu CD, Powe NR, McCulloch CE, et al. Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019. JAMA Netw Open. 2021;4(9):e2127014. doi:10.1001/jamanetworkopen.2021.27014
  2. Claudel, Sophie E.1; Schmidt, Insa M.2; Verma, Ashish2. A Call for Implementation Science: Achieving Equitable Access to SGLT2 Inhibitors. Kidney360 3(5):p 942-944, May 26, 2022. | DOI: 10.34067/KID.0001512022
  3. Chu CD, Lamprea-Montealegre JA, Estrella MM. Too Many for Too Few: Finding Appropriate Nephrology Referrals for Patients With CKD That Optimize Outcomes. Am J Kidney Dis. 2022 Mar;79(3):330-332. doi: 10.1053/j.ajkd.2021.09.020. Epub 2022 Jan 12. PMID: 35031165.
  4. Schmieder RE. Renal denervation: where do we stand and what is the relevance to the nephrologist? Nephrol Dial Transplant. 2022 Mar 25;37(4):638-644. doi: 10.1093/ndt/gfaa237. PMID: 33200209.
  5. Veelken, J Am Soc Nephrol, 2008, 19(7): 1371
  6. Ong, J Neurophysiol, 2019; 122(1): 358

Joint Accreditation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:
Manisha Jhamb, MD, MPH — Associate Professor of Medicine, Associate Chief, Renal-Electrolyte Division, Director, Center for Population Health Management, Co-Director, Clinical Research, Renal-Electrolyte Division, Division of Renal-Electrolyte, University of Pittsburgh School of Medicine
Dr. Jhamb is a consultant with Xcenda, LLC; and Boehringer Ingelheim, LLC. Dr. Jhamb also receives grant/research support from Bayer, and Pfizer.
Roderick Tan, MD, PhD — Assistant Professor of Medicine, Division of Renal-Electrolyte, University of Pittsburgh School of Medicine
No relationships with industry relevant to the content of this educational activity have been disclosed.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.